Product How it works Pricing Blog FAQ About Contact
Puma Biotechnology

Puma Biotechnology (NASDAQ: PBYI) revenue

Puma Biotechnology reported revenue of $228.4m for fiscal 2025, 0.9% less than in fiscal 2024 ($230.5m). Since fiscal 2017 its revenue has grown by 724.9%, an average growth of 30.2% a year.

Puma Biotechnology's revenue has fallen for 2 years in a row, and its best year of the last 9 was fiscal 2019. The biggest drop was in fiscal 2020, −17.3%.

Revenue, in millions of US dollars27.72017251.02018272.32019225.12020253.22021228.02022235.62023230.52024228.42025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025$228.4m−0.9%$37.3m16.3%
2024$230.5m−2.2%$31.0m13.4%
2023$235.6m+3.3%$32.6m13.9%
2022$228.0m−9.9%$23.7m10.4%
2021$253.2m+12.5%$1.3m0.5%
2020$225.1m−17.3%−$30.4m−13.5%
2019$272.3m+8.5%−$39.0m−14.3%
2018$251.0m+806.6%−$94.7m−37.7%
2017$27.7m—−$292.4m−1,056.1%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Puma Biotechnology revenue compared with its sector

By revenue for its latest fiscal year, Puma Biotechnology ranks 242nd of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Puma Biotechnology, −0.9%.

RankCompanyRevenueRevenue growth
240thAnaptysbio$234.6m157.0%
241stCerus$233.8m16.1%
242ndPuma Biotechnology$228.4m−0.9%
243rdAxogen$225.2m20.2%
244thIDEAYA Biosciences$218.7m3,024.4%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the revenue of Puma Biotechnology

How much revenue did Puma Biotechnology make in fiscal 2025?
Puma Biotechnology reported revenue of $228.4m for fiscal 2025, compared with $230.5m in fiscal 2024.
How much has the revenue of Puma Biotechnology grown?
Between fiscal 2017 and fiscal 2025 it went from $27.7m to $228.4m: 724.9% more, an average growth of 30.2% a year.
What was the best year for revenue at Puma Biotechnology?
Of its last 9 fiscal years, fiscal 2019, with $272.3m.
Where does Puma Biotechnology rank in its sector by revenue?
It ranks 242nd of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Puma Biotechnology come from?
From the annual report (Form 10-K) that Puma Biotechnology files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Puma Biotechnology files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Puma Biotechnology: the Puma Biotechnology page · annual accounts · net income · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.